Emergent BioSlutions Inc (NYSE:EBS) to Hold Annual Meeting of Stockholders May 21

Emergent BioSolutions Inc (NYSE:EBS) will hold their annual meeting of stock holders on Wednesday, May 21 at 10:00 am ET.  The meeting will be recording and available via webcast at emergentbiosolutions.com.  Interested parties may also listen by dialing 800-561-2693 or 617-614-3523 for international callers.  There is no passcode for the call.

Emergent BioSolutions Inc. (Emergent) is a multinational biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. It manufactures and market BioThrax, also referred to as anthrax vaccine adsorbed. It develops immunobiotics for use against infectious diseases that have resulted in significant unmet or underserved public health needs and against biological agents that are potential weapons of bioterrorism and biowarfare.

In addition to its licensed BioThrax product, it has product candidates in both advanced and earlier stages of development. Its advanced stage product candidates consist of an anthrax immune globulin therapeutic candidate, a typhoid vaccine candidate and a hepatitis B therapeutic vaccine candidate. Its earlier stage programs include botulinum vaccines, group B streptococcus vaccine and chlamydia vaccine candidates.